Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;26(5):916-925.
doi: 10.1111/codi.16939. Epub 2024 Mar 11.

Does complete pathological response increase perioperative morbidity risk in rectal cancer?

Thomas K S Tiang  1 , Adrian S S Yeoh  1 , Bushra Othman  2 , Helen M Mohan  2 , Adele N Burgess  1 , Philip J Smart  1 , David M Proud  1
Affiliations

Does complete pathological response increase perioperative morbidity risk in rectal cancer?

Thomas K S Tiang et al. Colorectal Dis. 2024 May.

Abstract

Aim: The optimal management of patients with clinical complete response after neoadjuvant treatment for rectal cancer is controversial. The aim of this study is to compare the morbidity between patients with locally advanced rectal cancer who have had a pathological complete response (pCR) or not after neoadjuvant chemoradiotherapy (NCRT) and total mesorectal excision (TME). The study hypothesis was that pCR may impact the surgical complication rate.

Method: A retrospective cohort study was conducted of a prospectively maintained database in Australia and New Zealand, the Binational Colorectal Cancer Audit, that identified patients with locally advanced rectal cancer (<15 cm from anal verge) from 1 January 2007 to 31 December 2019. Patients were included if they had locally advanced rectal cancer and had undergone NCRT and proceeded to surgical resection.

Results: There were 4584 patients who satisfied the inclusion criteria, 65% being male. The mean age was 63 years and 11% had a pCR (ypT0N0). TME with anastomosis was performed in 67.8% of patients, and the majority of the cohort received long-course radiotherapy (81.7%). Both major and minor complications were higher in the TME without anastomosis group (17.3% vs. 14.7% and 30.6% vs. 20.8%, respectively), and the 30-day mortality was 1.31%. In the TME with anastomosis group, pCR did not contribute to higher rates of surgical complications, but male gender (p < 0.0012), age (p < 0.0001), preoperative N stage (p = 0.0092) and American Society of Anesthesologists (ASA) score ≥3 (p < 0.0002) did. In addition, pCR had no significant effect (p = 0.44) but male gender (p = 0.0047) and interval to surgery (p = 0.015) contributed to higher rates of anastomotic leak. In the TME without anastomosis cohort, the only variable that contributed to higher rates of complications was ASA score ≥3 (p = 0.033).

Conclusion: Patients undergoing TME dissection for rectal cancer following NCRT showed no difference in complications whether they had achieved pCR or not.

Keywords: complete pathological response; radiochemotherapy; rectal cancer; total mesorectal excision.

PubMed Disclaimer

References

REFERENCES

    1. Field K, Yip D, Bokey L, Gormly K, Heriot A, Hruby G, et al. Optimal timing surgery after neoadjuvant therapy. clinical guidelines network. Cancer Council Australia; 2017. https://wiki.cancer.org.au/australia/Guidelines:Colorectal_cancer/Optima...
    1. van der Sluis FJ, Couwenberg AM, de Bock GH, Intven MPW, Reerink O, van Leeuwen BL, et al. Population‐based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer. Br J Surg. 2020;107(1):131–139. https://doi.org/10.1002/bjs.11324
    1. Fahima D, Chesney TR, Acuna SA, Baxter NN. A Watch‐and‐wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta‐analysis. Lancet Gastroenterol Hepatol. 2017;2(7):501–513. https://doi.org/10.1016/S2468‐1253(17)30074‐2
    1. Coraglio MF, Eleta MA, Kujaruk MR, Oviedo JH, Roca EL, Masciangioli GA, et al. Analysis of long‐term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer. World J Surg Oncol. 2020;18(1):313. https://doi.org/10.1186/s12957‐020‐02094‐1
    1. Smith JJ, Strombom P, Chow OS, Roxburgh CS, Lynn P, Eaton A, et al. Assessment of a Watch‐and‐wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol. 2019;5(4):e185896. https://doi.org/10.1001/jamaoncol.2018.5896

MeSH terms

LinkOut - more resources